Literature DB >> 11276201

Defining the specific physiological requirements for c-Myc in T cell development.

N C Douglas1, H Jacobs, A L Bothwell, A C Hayday.   

Abstract

c-Myc is associated with cell growth and cycling in many tissues and its deregulated expression is causally implicated in cancer, particularly lymphomagenesis. However, the contribution of c-Myc to lymphocyte development is unresolved. We show here that the formation of normal lymphocytes by c-Myc-/- cells is selectively defective. c-Myc-/- cells are inefficient, in an age-dependent manner, at populating the thymus, and subsequent thymocyte maturation is ineffective: they fail to grow and proliferate normally at the late double-negative (DN) CD4-CD8- stage. Because N-Myc expression in thymocytes usually declines at the late DN stage, these results confirm that the nonredundant contributions of Myc family members to development are related to their distinct patterns of developmental gene expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11276201     DOI: 10.1038/86308

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  43 in total

1.  myc maintains embryonic stem cell pluripotency and self-renewal.

Authors:  Natalia V Varlakhanova; Rebecca F Cotterman; Wilhelmine N deVries; Judy Morgan; Leah Rae Donahue; Stephen Murray; Barbara B Knowles; Paul S Knoepfler
Journal:  Differentiation       Date:  2010-05-27       Impact factor: 3.880

2.  Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1.

Authors:  Brian M Iritani; Jeffrey Delrow; Carla Grandori; Ivan Gomez; Meredith Klacking; Leni Sue Carlos; Robert N Eisenman
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

3.  HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRβ-selected mouse thymocytes.

Authors:  Gladys W Wong; Gisele C Knowles; Tak W Mak; Adolfo A Ferrando; Juan Carlos Zúñiga-Pflücker
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

Review 4.  Metabolic regulation of T cell differentiation and function.

Authors:  Benjamin V Park; Fan Pan
Journal:  Mol Immunol       Date:  2015-08-12       Impact factor: 4.407

5.  The protooncogene MYC can break B cell tolerance.

Authors:  Yosef Refaeli; Kenneth A Field; Brian C Turner; Andreas Trumpp; J Michael Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

6.  Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.

Authors:  Shala Dezfouli; Antony Bakke; Jie Huang; Anthony Wynshaw-Boris; Peter J Hurlin
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

7.  Productive coupling of accessible Vbeta14 segments and DJbeta complexes determines the frequency of Vbeta14 rearrangement.

Authors:  Sheila Ranganath; Andrea C Carpenter; Megan Gleason; Albert C Shaw; Craig H Bassing; Frederick W Alt
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

8.  Intrathymic proliferation wave essential for Valpha14+ natural killer T cell development depends on c-Myc.

Authors:  Marei Dose; Barry P Sleckman; Jin Han; Andrea L Bredemeyer; Albert Bendelac; Fotini Gounari
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-07       Impact factor: 11.205

9.  c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.

Authors:  Yinshi Guo; Chao Niu; Peter Breslin; Minghui Tang; Shubin Zhang; Wei Wei; Ameet R Kini; Gladell P Paner; Serhan Alkan; Stephan W Morris; Manuel Diaz; Patrick J Stiff; Jiwang Zhang
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

10.  Interactions between Ras1, dMyc, and dPI3K signaling in the developing Drosophila wing.

Authors:  David A Prober; Bruce A Edgar
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.